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Cell deathe organized and not randomly distributed in the cell membrane. In particular,
sphingolipids seem to interact with cholesterol in the outer leaﬂet of the cell membrane resulting in the
formation of distinct membrane domains, i.e. rafts. The generation of ceramide within rafts alters their
biophysical properties and results in the formation of large ceramide-enriched membrane platforms.
These platforms serve to cluster receptor molecules and to organize intracellular signalling molecules to
facilitate signal transduction via a receptor upon stimulation. Thus, ceramide-enriched membrane
domains amplify not only receptor-, but also stress-mediated signalling events. Although many receptors
cluster, the molecular mechanisms mediating this important and general event in signal transduction
need to be identiﬁed.
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Sphingolipids, (glycerol-)phospholipids and cholesterol are the
major components of biological membranes in eukaryotic cells [1].
Sphingolipids consist of an sphingoid base, i.e. a 1,3-dihydroxy-2-
aminoalken backbone. Sphingosine, which is (2S, 3R, 4E)-2-amino-4-
octadecene-1,3-diol, is the most prevalent backbone of mammalian
sphingolipids. Sphingoid bases vary in length of the alkyl chain and
position and number of the double bonds. Ceramide is generated from
sphingosine by attachment of a fatty acid via an amide ester bond
[1,2]. The fatty acids in ceramides vary between 2 and 28 carbon atoms
in the acyl chain and saturation. Ceramides are further modiﬁed by
attachments of headgroups to form, for instance, sphingomyelin,
gangliosides, sulfatides, globosides or cerebrosides [1–3].
Studies in the last years revealed that lipids in cell membranes do
not form a homogenous liquid phase [4], but are ordered into domainsiology and Center of Medical
e 55, 45122 Essen, Germany.
s).
ll rights reserved.mediated by interactions of, for instance, sphingolipids and choles-
terol [5]. Sphingomyelin is the most prevalent cellular sphingolipid,
which is synthesized on the luminal side of the Golgi apparatus or the
plasma membrane, and, thus, localizes predominantly to anti-
cytoplasmic leaﬂets of the cell membrane and intracellular vesicles
[6–8]. This distribution pattern of sphingomyelin results in lipid
bilayer asymmetry, which is critical for the genesis of distinct
membrane domains and, as discussed below, signal transduction.
Sphingomyelin is comprised of a highly hydrophobic ceramide moiety
and a hydrophilic phosphorylcholine headgroup [2,3]. The hydrophilic
phosphorylcholine groups tightly interact with each other, other
hydrophilic headgroups of glycosphingolipids and the hydrophilic
parts of cholesterol [3,9,10]. The ceramide moiety of sphingomyelin
binds to cholesterol via hydrophobic van der Waal interactions
[3,9,10]. The tight hydrophilic and hydrophobic interactions and the
high local concentration of sphingolipids and cholesterol mediate a
lateral association of these lipids in the cell membrane, separation
from other phospholipids within the bilayer and the spontaneous
formation of distinct domains [3,9,10]. These very small, tightly
packed sphingolipid- and cholesterol-enriched membrane domains
are named rafts that seem to exist in a more ordered liquid phase than
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cholesterol precursors do not only interact with sphingolipids in these
rafts, but also stabilize the structure of rafts by ﬁlling void spaces
between the bulky sphingolipids [9,11]. This notion is consistent with
the ﬁnding that extraction of cholesterol frommembranes using drugs
as beta-cyclodextrin, nystatin or ﬁlipin destroys membrane rafts [12].
Many studies characterized rafts by their resistance to detergents,
which are caused by the high biophysical order in this phase, although
the use of detergents might be problematic to investigate the
physiology of lipids and detergent-resistant membrane domains are
not the same as membrane rafts [13,14].
2. Ceramide-enriched membrane domains
Hydrolysis of sphingomyelin results in the release of ceramide,
which is catalyzed by acid, neutral and alkaline sphingomyelinases
with the respective pH optimum of activity [3,15]. Ceramide is also
formed in cellular membranes by de novo synthesis via a pathway
involving the serine-palmitoyl-CoA transferase as the key enzyme.
Recent studies further revealed three additional pathways for the
formation of ceramide, i.e. by the reverse activity of the acid
ceramidase catalyzing synthesis of ceramide from sphingosine [16],
by hydrolysis of complex-glycosylated lipids [17] and by hydrolysis of
ceramide-1-phosphate [18].
Acid sphingomyelinase is the best-characterized sphingomyelinase
and the enzymewas shown to be critically involved inmany formsof cell
activation [19]. The acid sphingomyelinase exists in two forms, a
lysosomal acid sphingomyelinase and a secretory acid sphingomyelinase
that are both derived from the samegene, but differ in their glycosylation
pattern and are also differentially processed at the NH2-terminus [20].
Acid sphingomyelinase was in addition shown to bind to the
extracellular leaﬂet of the cell membrane [21,22], however, at present
it is unknown whether this form is a third isoform or a specialized
form of the secretory or lysosomal acid sphingomyelinase.
The in vivo mechanisms that mediate activation of the acid
sphingomyelinase are still unknown. It was shown that CD95 mediates
activation of the acid sphingomyelinase by a caspase 8 dependent
pathway, since CrmA or Ac-YVAD-cmk, viral or pharmacological blocker,
respectively, of some caspases prevent stimulation of the acid sphingo-
myelinase [23,24]. Likewise, overexpressionof caspase8, or constitutively
active caspase 8 mutants resulted in increased ceramide release [25].
The Tumor Necrosis Factor Receptor (TNF-R), another receptor well
known to stimulate the acid sphingomyelinase [26], seems to mediate
acid sphingomyelinase activation independent of caspase 8 via a yet
unknown initiator caspase [27]. Acid sphingomyelinase was also
shown to associate with phosphatidylinositol-3-kinase (PI-3-K) and
the CD161 molecule [28,29]. While it is unknown how CD161
regulates acid sphingomyelinase, activation of PI-3-K by nerve growth
factor (NGF) triggering resulted in an approximately 50% reduction of
acid sphingomyelinase activity suggesting that phoshatidylinositol-
phosphates are able to regulate acid sphingomyelinase [28,30].
An additional study demonstrated that oxidation of cysteine 629 of
acid sphingomyelinase mediates activation of the enzyme, although it
has to be determined whether this amino acid residue is oxidized in
vivo to regulate the enzyme [31]. Recent studies have supported the
view that reactive oxygen species (ROS) regulate sphingomyelinase-
mediated formation of signalling platforms in mammalian cells
induced by various ligands or stimuli. Charruyer et al. described that
UV-C irradiation resulted in redox-dependent activation and trans-
localization of acid sphingomyelinase to the external surface of
membrane microdomains, hydrolysis of sphingomyelin associated
with the plasma membrane outer leaﬂet, ceramide generation and
apoptosis [32]. Further, TNF-related apoptosis-inducing ligand (TRAIL)
induced a rapid release of ROS and the antioxidants Tiron or N-
acetylcysteine blocked TRAIL-induced formation of ceramide-
enriched membrane lipid raft platforms and apoptosis in BJAB orsplenocytes [33]. Likewise, γ-irradiation of a radiosensitive human
head and neck squamous carcinoma cell line (SCC61) results in the
formation of raft platforms associated with the externalization of an
acid sphingomyelinase, leading to ceramide release and apoptosis and
these events were abolished by ROS scavengers [34].
Finally, recent in vitro studies suggest that the concentration of
ceramide itself inﬂuences the activity of the enzyme, at least in model
membranes [35].
The release of ceramide within the cell membrane alters the
biophysical characteristics of membranes, which was ﬁrst demon-
strated by in vitro studies showing that addition of ceramide to
dipalmitoylphosphatidylcholine bilayers induced lateral phase
separation into domains with gel and liquid crystalline phases,
respectively [36]. Ceramide molecules spontaneously associate and
tightly bind with other ceramide molecules resulting in the formation
of small ceramide-enriched membrane microdomains [3,21,37,38].
The accumulation of ceramide very likely occurs in the above-
described membrane rafts, although this has not been formally
proven. Since ceramide molecules displace cholesterol from rafts, at
least in artiﬁcial membranes [37], the generation of ceramide within
rafts may also completely alter the composition of rafts. Ceramide-
enriched microdomains have the tendency to spontaneously fuse and
to form ceramide-enriched macrodomains, also named ceramide-
enriched membrane platforms, with a diameter between a few
hundred nanometers up to several micrometers [21,22] (Fig. 1).
Relative low concentrations, i.e. as little as 5 mol% ceramide in model
membranes, are required for spontaneous formation of ceramide-
enriched membrane domains [38].
Ceramide-enriched membrane domains seem to be tightly packed
and, thus, rather stabile membrane domains, consistent with the
observation that ceramide promotes the formation of membrane
domains into a liquid ordered state [3,37,38].
Ceramide-enriched membrane domains were demonstrated in
living cells by ﬂuorescence microscopy [21,39]. Studies on phospha-
tidylcholine/sphingomyelin-composed unilamellar vesicle that were
treated with sphingomyelinase immobilized onto a microbead
conﬁrmed the formation of ceramide-enriched membrane macro-
domains [40].
The formation of distinct membrane domains by ceramide is also
indicated by magnetic resonance spectroscopy and atomic force
microscopy studies that revealed laminar phase separation of long
chain ceramides in glycerophospholipid/cholesterol bilayers and
formation of stable, distinct domains that correspondwith a transition
of ﬂuid phospholipid bilayers into a gel-like phase [38,41]. Finally,
biophysical studies demonstrated that small amounts of ceramide
signiﬁcantly increased the gel-to-ﬂuid transition temperature of
sphingomyelin suggesting the formation and stabilization of a liquid
ordered state [41].
3. Function of ceramide-enriched membrane platforms and
receptor clustering
The accumulation of ceramide within cellular membranes results
in the formation of membrane domains with altered biophysical
properties. Thus, ceramide-enriched membrane domains are perfect
structures to sort proteins in cells and to provide amean for the spatial
re-organization of receptors and intracellular signalling molecules
upon cellular stimulation. Ceramide-enriched membrane platforms
were shown to trap and, thus, cluster receptor molecules [21–
23,40,42]. Clustering of receptor molecules results in a very high
receptor density within a small area of the cell membrane, a
phenomenon that is required for the transmission of signals via
many receptor molecules. Receptor aggregation and trapping in
ceramide-enriched membrane domains may limit lateral diffusion
and, thus, stabilize the interaction of a ligand with its receptor, in
particular if the ligand is also trapped in distinct membrane domains.
Fig. 1. CD95 stimulation induces ceramide-enriched membrane platforms. Stimulation of Jurkat T-lymphocytes via CD95 results in the formation of ceramide-enriched membrane
platforms on the cell surface. Cells were stimulated, ﬁxed, stained with Cy3-coupled anti-ceramide antibodies and analyzed by confocal microscopy.
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rafts or ceramide-enriched membrane domains has been shown for
the CD95/CD95 ligand and CD40/CD40 ligand pairs [21,39,43,44]. The
interaction of ligand-bound receptors with the very hydrophobic
ceramide-enriched membrane platform and/or individual ceramide
molecules may in addition stabilize conformational changes that may
occur upon activation of a receptor by its ligand. Clustering of
receptors also results in clustering of receptor-associated signalling
molecules within or at ceramide-enriched domains. Furthermore,
ceramide-enrichedmembrane domains, although present in the outer
leaﬂet of the cell membrane, may sort intracellular signalling
molecules, for instance via farnesyl- or geranyl-moieties. This sorting
function may result in the spatial association of activated receptors
with signalling molecules that transmit the signal from the receptor
into the cell, while at the same time inhibitory molecules are excluded
from this area of the cells. In addition, a high concentration and close
vicinity of enzymes may permit enhanced transactivation of enzymes
associating with the activated receptor, for instance of caspases
associating with death receptor.
These considerations suggest that ceramide-enriched membrane
platforms have a general function in signal transduction, i.e. they mayFig. 2. CD95 induces surface exposure of the acid sphingomyelinase. Stimulation of Jurkat T-ly
were ﬁxed, stained with gold-coupled anti-acid sphingomyelinase antibodies and analyzed
Printed with permission of the JBC.primarily function to spatially organize receptors and the intracellular
signalosome in and at the cell membrane to facilitate and amplify
signalling processes. This general function of ceramide-enriched
membrane domains is also consistent with the ﬁnding that many
diverse receptors and stimuli trigger the release of ceramide and the
formation of ceramide-enriched membrane domains, including
CD95 [21–23,42], CD40 [39], DR5 [34], FcγRII [45], the PAF-receptor
[46], CD14 [47], infection with P. aeruginosa [48], S. aureus [49], N.
gonorrhoeae [50,51], Rhinovirus [52], application of stress stimuli such
as γ-irradiation [53], UV-light [32,54–56], cisplatin [57], gemcitabine
[58], Cu2+-treatment [59] and in some conditions of developmental
death [60].
The function of ceramide-enriched membrane domains is best
studied for CD95. CD95 ligation results in activation of the acid
sphingomyelinase, mobilization of intracellular vesicles that contain
the acid sphingomyelinase and, thus, translocation of the enzyme onto
the extracellular leaﬂet of the cell membrane and the release of
extracellularly-oriented ceramide [21,22] (Figs. 1 and 2). Ceramide
molecules form ceramide-enriched membrane platforms that serve to
cluster CD95 resulting in a very high density of CD95molecules within
a small and described area of the membrane [21,22,42] (Fig. 1). Thismphocytes results in surface exposure of acid sphingomyelinase on the cell surface. Cells
by scanning electron microscopy. The gold particles are visualized as small white dots.
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cells, SKW 6.4 and JY B cell lymphoma, H9 T cell lymphoma, epithelial
andmouse granulosa cells, lung epithelial cells and in primary murine
splenocytes and hepatocytes [61].
Destruction of rafts also abrogated the assembly of CD95 with
downstream signalling molecules such as FADD or caspase 8
indicating that ceramide-enriched membrane domains do not only
serve the clustering of receptors [62].
The ampliﬁcation function of ceramide-enriched membrane plat-
forms for CD95 signalling was shown on B-lymphocytes lacking
functional acid sphingomyelinase expression [21,22,42]. These cells
fail to release ceramide upon CD95 stimulation. Binding of CD95
ligands to CD95 only resulted in a very weak activation in these cells as
indicated by levels of recruitment of FADD and stimulation of caspase
8 that only reached approximately 1% of the levels achieved after
maximal activation of CD95 in wild type, acid sphingomyelinase-
positive cells. Formation of ceramide-enriched membrane platforms
by addition of C16-ceramide restored CD95 clustering and CD95-
initiated signalling in acid sphingomyelinase-deﬁcient cells.
These studies demonstrate that ceramide-enriched membrane
platforms serve to cluster activated receptor molecules and provide a
feed-forward mechanism resulting in recruitment of signalling
molecules and marked ampliﬁcation of a primary weak signal.
4. Mechanisms of receptor clustering in ceramide-enriched
membrane domains
Although receptor clustering has been shown for many receptor
molecules including CD95, DR5, the T cell receptor/CD3 complex
[63,64], B cell receptor [65,66], CD40 [39,67–69], Fcɛ receptor 1 [70],
CD28 [71], TNF-R [72], platelet-derived growth factor receptor [73] to
name a few, the mechanisms, mediating the clustering of receptors,
particular in rafts and ceramide-enriched membrane domains, are
only poorly characterized.
First insights into themolecular mechanisms of receptor clustering
were provided by studies on the CD40 receptor [74]. CD40 is recruited
to and clusters in sphingolipid-enriched rafts of dendritic cells and B-
lymphocytes [39,67–69]. Furthermore, it was shown that CD40
clusters in ceramide-enriched membrane domains after stimulation,
an event that was required for the initiation of CD40 signalling [39].
In contrast, the tyrosine phosphatase CD45 was shown to be
excluded from lipid rafts [66,75,76], at least in many cells. This
difference in spatial distribution was employed to test the role of the
transmembranous role of CD40 for a preferential partitioning into
ceramide-enriched membrane domains. In these studies, the mem-
brane-spanning region of CD40 was exchanged with the transmem-
branous domain of the protein tyrosine phosphatase CD45 [74]. These
studies revealed clustering of CD40 in ceramide-enriched membrane
platforms, which was not observed with the CD40/45 chimera after
stimulation. In fact the CD40/45 chimerawas excluded from lipid rafts
and platforms very similar to CD45. The mutant also failed to initiate
signals in cells upon stimulation that were observed after stimulation
via CD40, for instance phosphorylation of p38MAPK. However, forced
cross-linking of the CD40/CD45 mutant was sufﬁcient to trigger
phosphorylation of p38MAPK [74].
These data support the notion that clustering of CD40 in
membrane platforms serves to initiate a high local concentration
of receptor molecules, which initiates and ampliﬁes signal transduc-
tion. However, since artiﬁcial clustering is not sufﬁcient to fully
restore CD40 signalling, clustering of CD40 in rafts and ceramide-
enriched membrane domains, respectively, might also have addi-
tional functions for the transmission of signals via CD40. Those
functions could be exclusion of inhibitory signalling molecules, e.g.
CD45, direct modiﬁcation of CD40 signalling by ceramide and/or
stabilization of the receptor–ligand interaction by a limitation of
lateral diffusion.The transmembranous domains of CD40 and CD45 are both
composed of 22 amino acids suggesting that preferential partitioning
of a receptor is mediated by a preferred interaction of individual
amino acid residues with rafts and ceramide-enriched membrane
platforms, while the length of the transmembranous domain might
be less important. The transmembranous domain of CD40 contains
three phenylalanine residues and otherwise only uncharged amino
acids, which might mediate preferential integration of the receptor in
hydrophobic, ceramide-enriched membrane platforms. In contrast,
the transmembranous domain of CD45 is less hydrophobic with
central threonine and serine residues containing aliphatic hydroxyl
side chains and a tyrosine residue at the interface to the cytosol, a
pattern that may exclude the protein from ceramide-enriched
membrane platforms. In addition, binding of the ligand to its
receptor may alter the conformation of the transmembranous
domain in the receptor molecule. Since ceramide-enriched mem-
brane domains may have a different diameter than other domains of
the plasma membrane, an alteration of the length of the transmem-
branous domain of a receptor upon ligand binding may facilitate
integration into ceramide-enriched membrane domains. However, at
present the molecular and structural determinants that ﬁnally
mediate clustering of a certain receptor molecule in rafts remain to
be elucidated.
5. Conclusions
Many studies in the last ten years demonstrated the central role
of rafts and ceramide-enriched membrane domains for the
initiation and ampliﬁcation of receptor and stress-mediated signal-
ling in almost all cell types. Although these studies provided novel
concepts for the understanding of signalling networks within cells,
in particular the spatial organization of signalling networks, at
present no drugs exist that speciﬁcally target rafts or ceramide-
enriched membrane domains to either prevent or amplify their
function. The development of those drugs might open novel
opportunities to treat infectious diseases, degenerative disorders
and malignant tumors. Thus, it could be envisioned that local
generation or application of ceramide to tumors prevents tumor
growth or acts synergistically with γ-irradiation or chemotherapy,
respectively. This concept has been recently proved in animal
experiments [77]. Further, since many drugs seem to kill tumor
cells via ceramide an inhibition of the acid ceramidase to prevent
ceramide degradation might promote the effects of chemotherapy
and γ-irradiation on the tumor, although the problem of a local
inhibition of the acid ceramidase remains to be solved. Diseases
with an increased formation of ceramide for instance cystic ﬁbrosis
[78] or chronic obstructive pulmonary disorder [79] might be
treated with inhibitors of the acid sphingomyelinase and ﬁrst
clinical trials are already ongoing to treat cystic ﬁbrosis with drugs
that inhibit the acid sphingomyelinase. Other disorders such as
Alzheimer's disease that has been described to be linked to
increased concentrations of ceramide [80] might also be treated
by inhibition of ceramide generation. The inhibition of infectious
diseases by a manipulation of the ceramide-metabolism is certainly
much more difﬁcult, since ceramide seems to have multiple and,
most importantly, not yet completely deﬁned functions in infec-
tious biology.
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